Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
53,004,129
-
Share change
-
-792,967
-
Total reported value
-
$1,736,029,929
-
Put/Call ratio
-
405%
-
Price per share
-
$32.77
-
Number of holders
-
157
-
Value change
-
-$24,504,359
-
Number of buys
-
85
-
Number of sells
-
55
Institutional Holders of ALDER BIOPHARMACEUTICALS INC - COM (ALDR) as of Q3 2016
As of 30 Sep 2016,
ALDER BIOPHARMACEUTICALS INC - COM (ALDR) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,004,129 shares.
The largest 10 holders included
FMR LLC, JANUS CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Partner Fund Management, L.P., BlackRock Fund Advisors, Cormorant Asset Management, LLC, BB BIOTECH AG, Foresite Capital Management III, LLC, and STATE STREET CORP.
This page lists
157
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.